Else Kröner Fresenius Stiftung

Funding for young researchers

New call for young researcher funding applications each year

In targeted competitive calls for applications, the EKFS offers a broad range of measures for the support of young researchers and, in particular, Clinician Scientists.

The individual grants and coordinated programmes accompany the entire career path: from the medical student or life scientist with a passion for research, to the internationally successful senior research consultant:

  • Else Kröner-Promotionskollegien for medical students
  • Else Kröner-Fresenius-Förderinitiative for top foreign medical researchers

Else Kröner-Memorial-Stipendien

Once again this year, the Else Kröner-Fresenius Foundation is dedicating one competitive call for applications to funding for young medical researchers. 

Else Kröner Memorial Stipendien are individual fellowships for young physicians in further education, who wish to implement a two-year project. Funding is capped at €90,000 salary plus €20,000 for material resources p.a. for two years. Three fellowships are awarded nationwide throughout Germany. Interested physicians are asked to apply in person.

Deadline: 12.4.2018 - finished


Else Kröner-Exzellenzstipendium

The Else Kröner-Exzellenzstipendium grants clinicians at senior consultant level a two-year leave of absence for an intensive research phase. Applicants must be able to produce evidence of outstanding research achievements and be clinically active in a position of responsibility.

The funding volume per fellowship includes €300,000 for two years to cover salary and material resources.

Deadline: 7.8.2018


Else Kröner-Promotionskolleg for medical students

The Else Kröner Promotionskolleg für Medizinstudenten offer the scholars the opportunity to focus entirely on their thesis for at least one year in a scientifically promising research project – embedded in an inspirational environment with experienced and committed supervisors.

In order to participate, both the supervisors and the scholars must qualify in a careful selection process. The major objective: To achieve results within the scope of the doctoral thesis, which meets with international and scientific response in the form of a lead author paper.  The maximum funding volume per research college and location amounts to €750,000 for three years, with the option of a second period.

The next call for proposals is expectet in 2020.


Else Kröner-Forschungskollegien for Physicians

The Else Kröner Forschungskollegien for Physicians are an innovative tool in the German funding landscape and are geared to research-intensive university hospitals. The scholars can focus fully on their research project for one to two years and work on a joint subject area within a scientifically excellent research group. An accompanying curriculum also creates an extensive knowledge base and establishes contacts with international experts. The maximum funding volume per research college amounts to €1.0 million for three years, with the option of a second funding period.

Deadline: 2.5.2018 - finished

Overview of current research colleges

  • Prof. Dr. Jörg C. Kalff Innate immunity and chronic organ dysfunction, Bonn University Hospital (granted in 2011 for 3 years; one-time extension for a further 3 years following a successful review in 2014.)
  • Prof. Dr. Stephan Stilgenbauer Stem cells, aging and malignant transformation. From experimental model to clinical application, Ulm University Hospital (granted in 2011 for 3 years; one-time extension for a further 3 years following a successful review in 2014.)
  • Prof. Dr. Dr. Andreas Beilhack Interdisciplinary translational immunology, Würzburg University Hospital (granted in 2011 for 3 years; one-time extension for a further 3 years following a successful review in 2014.)
  • Prof. Dr. Gerd Walz Renal dysfunction as a complication of systemic diseases, Freiburg University Hospital (granted in 2013 for 3 years; one-time extension for a further 3 years following a successful review in 2016.)
  • Prof. Dr. Ulrike Protzer Microbial triggers as cause of diseases, Technical University of Munich (granted in 2013 for 3 years; one-time extension for a further 3 years following a successful review in 2016.)
  • Prof. Dr. Christoph Klein Rare diseases of the immune system - from the pathophysiology to the development of new treatment strategies, LMU Munich Paediatric Clinic and Polyclinic in the Dr. von Hauner’schen Children’s Hospital (granted in 2013 for 3 years; one-time extension for a further 3 years following a successful review in 2016.)
  • Prof. Dr. Matthias Dobbelstein Molecular therapy and prediction in colorectal carcinoma, University Medical Center Göttingen (granted in 2014 for 3 years; one-time extension for a further 3 years following a successful review in 2018.)
  • Prof. Dr. Simone Fulda Targeted therapy strategies in oncology ("Targeted Therapies"): from the molecular basis to clinical application, University Hospital Frankfurt a. Main (granted in 2014 for 3 years; one-time extension for a further 3 years following a successful review in 2018.)
  • Prof. Dr. Thomas Fischer The role of the inflammatory microenvironment for the development of preneoplasia: from the molecular signals to new treatment strategies, University Hospital Magdeburg (granted in 2014 for 3 years; one-time extension for a further 3 years following a successful review in 2018.)
  • Prof. Dr. Ghazaleh Tabatabai Therapy resistance in solid tumours, University Hospital Tübingen (granted in 2016 for 3 years.)
  • Prof. Dr. Marion Subklewe Immunotherapy in the treatment of cancer: mechanisms of action and resistance, LMU University Hospital of Munich (granted in 2016 for 3 years.)
  • Prof. Dr. Peter Falkai Translational psychiatry, LMU University Hospital of Munich (granted in 2016 for 3 years.)
  • Prof. Dr. Otto Witte Aging and disease: translational analysis of therapeutic interventions (AntiAge), University Hospital Jena (granted in 2016 for 3 years.)
  • Prof.Dr.Ali El-Armouche Dynamics of the phosphoproteome: Novel working principles and interdisciplinary concepts for the therapy of cancer, neurodegenerative disorders and diabetes, University Hospital Dresden (granted in 2017 for 3 years.)
  • Prof.Dr. Peter Oefner Interdisciplinary translational Immuno-Oncology, University Hospital Regensburg (granted in 2017 for 3 years.)
  • Prof.Dr.Heike Pahl Immunological Causes and Therapies of Cancer, University Hospital Freiburg (granted in 2017 for 3 years.)
  • Prof.Dr. Christian Reinhardt Targeting therapy-induced dynamic alterations within the cancer genome, University Hospital Köln (granted in 2017 for 3 years.)